Characterization of antibiotic resistance plasmids from Bordetella bronchiseptica

Journal of Antimicrobial Chemotherapy

Volumn 40, Issue 6, 1997, Pages 811-816

  Speakman, A J ^a   Binns, S H ^a   Osborn, A M ^a   Corkill, J E ^a   Kariuki, S ^a   Saunders, J R ^a   Dawson, S ^a   Gaskell, R M ^a   Hart, C A ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; CHLOROBENZOIC ACID DERIVATIVE; CLAVULANIC ACID; CLOXACILLIN; DOXYCYCLINE; EDETIC ACID; ENROFLOXACIN; MERCURIC CHLORIDE; PENICILLINASE; RESTRICTION ENDONUCLEASE; STREPTOMYCIN; SULFADIAZINE; SULFONAMIDE; TAZOBACTAM; TETRACYCLINE; TRIMETHOPRIM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BORDETELLA BRONCHISEPTICA; CONTROLLED STUDY; DRUG POTENCY; ENZYME INHIBITION; ESCHERICHIA COLI; GENE SEQUENCE; ISOELECTRIC POINT; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR WEIGHT; MULTIDRUG RESISTANCE; NONHUMAN; PLASMID;

ANIMALS; ANTI-BACTERIAL AGENTS; BORDETELLA BRONCHISEPTICA; CATS; MICROBIAL SENSITIVITY TESTS; R FACTORS; TETRACYCLINE RESISTANCE;

EID: 0031436474     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/40.6.811     Document Type: Article

References (49)

1. McCandlish, I. A. P., Thompson, H., Cornwell, H. J. C. & Wright, N. G. (1978). A study of dogs with kennel cough. Veterinary Record 102, 293-301.
2. Wagener, J. S., Sobonya, R., Minnich, L. & Taussig, L. M. (1984). Role of canine parainfluenza virus and Bordetella bronchiseptica in kennel cough. American Journal of Veterinary Research 45, 1862-6.
3. Dunne, H. W., Kradel, D. C. & Doty, R. B. (1961). Bordetella bronchiseptica (Brucella bronchiseptica) in pneumonia in young pigs. Journal of the American Veterinary Medical Association 139, 897-9.
4. Magyar, T., Chanter, N., Lax, A. J., Rutter, J. M. & Hall, G. A. (1988). The pathogenesis of turbinate atrophy in pigs caused by Bordetella bronchiseptica. Veterinary Microbiology 18, 135-46.
5. Ganaway, J. R., Allen, A. M. & McPherson, C. W. (1965). Prevention of acute Bordetella bronchiseptica pneumonia in a guinea pig colony. Laboratory Animal Care 15, 156-62.
6. Baskerville, M., Wood, M. & Baskerville, A. (1983). An outbreak of Bordetella bronchiseptica pneumonia in a colony of common marmosets (Callithrix jacchus). Laboratory Animals 17, 350-5.
7. Willoughby, K., Dawson, S., Jones, R. C., Symons, M., Daykin, J., Payne-Johnson, C. et al. (1991). Isolation of Bordetella bronchiseptica from kittens with pneumonia in a breeding cattery. Veterinary Record 129, 407-8.
8. Coutts, A. J., Dawson, S., Binns, S., Hart, C. A., Gaskell, C. J. & Gaskell, R. M. (1996). Studies on natural transmission of Bordetella bronchiseptica in cats. Veterinary Microbiology 48, 19-27.
9. Welsh, R. D. (1996). Bordetella bronchiseptica infections in cats. Journal of the American Animal Hospital Association 32, 153-8.
10. Woolfrey, B. F. & Moody, J. A. (1991). Human infections associated with Bordetella bronchiseptica. Clinical Microbiology Reviews 4, 243-55.
11. Tamion, F., Girault, C., Chevron, V., Pestel, M. & Bonmarchand, G. (1996). Bordetella bronchiseptica pneumonia with shock in an immunocompetent patient. Scandinavian Journal of Infectious Disease 28, 197-8.
12. Byrd, L. H., Anama, L., Gutkin, M. & Chmel, H. (1981). Bordetella bronchiseptica peritonitis associated with continuous ambulatory peritoneal dialysis. Journal of Clinical Microbiology 14, 232-3.
13. Katzenstein, D., Ciofalo, L. & Jordan, M. C. (1984). Bordetella bronchiseptica bacteremia. Western Journal of Medicine 140, 96-8.
14. Amador, C., Chiner, E., Calpe, J. L., Ortiz de la Table, V., Martinez, C. & Pasquau, F. (1991). Pneumonia due to Bordetella bronchiseptica in a patient with AIDS. Reviews of Infectious Diseases 13, 771-2.
15. Gueirard, P., Weber, C., Le Coustumier, A. & Guiso, N. (1995). Human Bordetella bronchiseptica infection related to contact with infected animals: persistence of bacteria in host. Journal of Clinical Microbiology 33, 2002-6.
16. Woodard, D. R., Cone, L. A. & Fostvedt, K. (1995). Bordetella bronchiseptica infection in patients with AIDS. Clinical Infectious Diseases 20, 193-4.
17. Hodges, R. T. & Young, G. W. (1984). Prevalence and in-vitro antimicrobial sensitivity of Bordetella bronchiseptica in the nasal cavity of pigs. New Zealand Veterinary Journal 32, 111-4.
18. Mengelers, M. J. B., van Klingeren, B. & van Miert, A. S. J. (1989). In vitro antimicrobial activity of sulfonamides against some porcine pathogens. American Journal of Veterinary Research 50, 1022-8.
19. Pedersen, M. M., Marson, E. & Pickett, M. J. (1970). Non-fermentative bacilli associated with man. III. Pathogenicity and antibiotic susceptibility. American Journal of Comparative Pathology 54, 178-92.
20. Fass, R. J. & Barnishan, J. (1980). In vitro susceptibilities of nonfermentative Gram-negative bacilli other than Pseudomonas aeruginosa to 32 antimicrobial agents. Reviews of Infectious Diseases 2, 841-53.
21. Hirsh, D. C. & Jang, S. (1994). Antimicrobial susceptibility of selected infectious bacterial agents obtained from dogs. Journal of the American Animal Hospital Association 30, 487-94.
22. Speakman, A. J., Binns, S. H., Dawson, S., Hart, C. A. & Gaskell, R. M. (1997). Antimicrobial susceptibility of Bordetella bronchiseptica isolates from cats and a comparison of the agar dilution and E-test methods. Veterinary Microbiology, in press.
23. Thrushfield, M. V., Aitken, C. G. G. & Muirhead, R. H. (1991). A field investigation of kennel cough: efficacy of different treatments. Journal of Small Animal Practice 32, 455-9.
24. Gaskell, R. M. & Dawson, S. (1994). Viral induced upper respiratory tract infection. In Feline Medicine and Therapeutics (Chandler, E. A., Gaskell, C. J. & Gaskell, R. M., Eds), pp. 453-72. Blackwell Scientific Publications, Oxford.
25. Terakado, N., Azechi, H., Ninomiya, K. & Shimzu, J. (1973). Demonstration of R factors in Bordetella bronchiseptica isolated from pigs. Antimicrobial Agents and Chemotherapy 3, 555-8.
26. Hedges, R. W., Jacob, A. E. & Smith, J. T. (1974). Properties of an R factor from Bordetella bronchiseptica. Journal of General Microbiology 84, 199-204.
27. Shimizu, M., Kuninori, K., Inoue, M. & Mitsuhashi, S. (1981). Drug resistance and R plasmids in Bordetella bronchiseptica isolates from pigs. Microbiology and Immunology 25, 773-86.
28. Graham, A. C. & Abruzzo, G. K. (1982). Occurrence and characterisation of plasmids in field isolates of Bordetella bronchiseptica. American Journal of Veterinary Research 43, 1852-5.
29. Lax, A. J. & Walker, C. A. (1986). Plasmids related to RSF1010 from Bordetella bronchiseptica. Plasmid 15, 210-6.
30. Datta, N. (1978). Plasmid-determined drug resistance. In Laboratory Methods in Antimicrobial Chemotherapy (Reeves, I. P., Williams, J. D. & Wise, R., Eds), Vol. 1, pp. 56-61. Churchill Livingstone, Edinburgh.
31. Birnboim, H. C. & Doly, J. (1979). A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Research 7, 1513-23.
32. Kariuki, S., Gilks, C., Corkill, J., Kimari, J., Benea, A., Waiyaki, P. et al. (1996). Multi-drug resistant non-typhi salmonellae in Kenya. Journal of Antimicrobial Chemotherapy 38, 425-34.
33. Thomas, C. M. & Thorsted, P. (1994). PCR probes for promiscuous plasmids. Microbiology 140, 1.
34. Devereux, J., Haeberli, P. & Smithies, O. (1984). A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Research 12, 387-95.
35. Kariuki, S., Mirza, N. B., Wasteson, Y., Senerwa, D., Gathuma, J. M. & Olsvik, O. (1992). Tetracycline resistance genes in Kenyan hospital isolates of Salmonella typhimurium. APMIS 100, 629-34.
36. Corkill, J. E., Hart, C. A., McLennan, A. G. & Aspinall, S. (1991). Characterization of a β-lactamase produced by Pseudomonas paucimobilis. Journal of General Microbiology 137, 1425-9.
37. Goering, R. V. (1993). Molecular epidemiology of nosocomial infection: analysis of chromosomal restriction fragment patterns by pulsed-field gel electrophoresis. Infection Control and Hospital Epidemiology 14, 595-600.
38. National Committee for Clinical Laboratory Standards. (1988). Performance Standards for Antimicrobial Susceptibility Testing. Tentative Standard M7-T2. NCCLS, Villanova, PA.
39. Smith, C. A. & Thomas, C. M. (1984). Nucleotide sequence of the trfA gene of broad host range plasmid RK2. Journal of Molecular Biology 175, 251-62.
40. Smith, C. A., Pinkney, M., Guiney, D. G. & Thomas, C. M. (1993). The ancestral IncP replication system consisted of contiguous oriV and trfA segments as deduced from a comparison of nucleotide sequences of diverse IncP plasmids. Journal of General Microbiology 139, 1761-6.
41. Thomas, C. M., Smith, C. A., Ibbotson, J. P., Johnson, L. & Wang, N. (1995). Evolution of the korA-oriV segment of promiscuous plasmids. Microbiology 141, 1201-10.
42. Bechhofer, D. H. & Figurski, D. H. (1983). Map location and nucleotide sequence of korA, a key regulatory gene of promiscuous plasmid RK2. Nucleic Acids Research 11, 7453-69.
43. Greene, C. E. (1990). Choice of appropriate antimicrobial therapy. In Infectious Diseases of the Dog and Cat, pp. 921-5. W. B. Saunders, Philadelphia. PA.
44. Terakado, N. & Mitsuhashi, S. (1974). Properties of R factors from Bordetella bronchiseptica. Antimicrobial Agents and Chemotherapy 6, 836-40.
45. Morris, J. S. & Luginbuhl, G. H. (1992). Conjugative plasmids in Bordetella avium. Plasmid 27, 251-5.
46. Speer, B. S., Shoemaker, N. B. & Salyers, A. A. (1992). Bacterial resistance to tetracycline: mechanisms, transfer and clinical significance. Clinical Microbiology Reviews 5, 387-99.
47. Andersen, S. R. & Sandaa, R. A. (1994). Distribution of tetracycline resistance determinants among Gram-negative bacteria isolated from polluted and unpolluted marine sediments. Applied and Environmental Microbiology 60, 908-12.
48. Bush, K. (1989). Characterization of β-lactamases. Antimicrobial Agents and Chemotherapy 33, 259-63.
49. Yaginuma, S., Terakado, N. & Mitsuhashi, S. (1975). Biochemical properties of a penicillin beta-lactamase mediated by R-factor from Bordetella bronchiseptica. Antimicrobial Agents and Chemotherapy 8, 238-42.